- Home
- ARAY vs SABA Comparison
ARAY vs SABA Comparison
Compare ARAY & SABA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARAY
- SABA
- Stock Information
- Founded
- ARAY 1990
- SABA 1988
- Country
- ARAY United States
- SABA United States
- Employees
- ARAY N/A
- SABA N/A
- Industry
- ARAY Medical/Dental Instruments
- SABA
- Sector
- ARAY Health Care
- SABA
- Exchange
- ARAY Nasdaq
- SABA Nasdaq
- Market Cap
- ARAY 229.3M
- SABA 233.0M
- IPO Year
- ARAY 2007
- SABA N/A
- Fundamental
- Price
- ARAY $1.52
- SABA $8.28
- Analyst Decision
- ARAY
- SABA
- Analyst Count
- ARAY 0
- SABA 0
- Target Price
- ARAY N/A
- SABA N/A
- AVG Volume (30 Days)
- ARAY 588.9K
- SABA 290.0K
- Earning Date
- ARAY 04-30-2025
- SABA 01-01-0001
- Dividend Yield
- ARAY N/A
- SABA 12.91%
- EPS Growth
- ARAY N/A
- SABA N/A
- EPS
- ARAY N/A
- SABA N/A
- Revenue
- ARAY $453,140,000.00
- SABA N/A
- Revenue This Year
- ARAY $6.97
- SABA N/A
- Revenue Next Year
- ARAY $5.02
- SABA N/A
- P/E Ratio
- ARAY N/A
- SABA N/A
- Revenue Growth
- ARAY 1.26
- SABA N/A
- 52 Week Low
- ARAY $1.40
- SABA $3.64
- 52 Week High
- ARAY $2.95
- SABA $4.42
- Technical
- Relative Strength Index (RSI)
- ARAY 37.95
- SABA 42.34
- Support Level
- ARAY $1.42
- SABA $8.00
- Resistance Level
- ARAY $1.55
- SABA $8.40
- Average True Range (ATR)
- ARAY 0.11
- SABA 0.27
- MACD
- ARAY -0.00
- SABA 0.01
- Stochastic Oscillator
- ARAY 23.86
- SABA 42.65
About ARAY Accuray Incorporated
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, innovative treatment solutions which set the standard of radiation therapy care with the aim of helping patients live better lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.
About SABA Saba Capital Income & Opportunities Fund II Shares of Beneficial Interest
Saba Capital Income & Opportunities Fund II is a closed-end fund. The company seeks high current income, with a secondary goal of capital appreciation. The fund invests in fixed income markets across the globe.